Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data

Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data

I've just noticed that the final version of a manuscript based on work by one of my ex-PhD students while under my supervision has finally been published. This is an interesting look at the mechanisms of gene loss (and gain) in prostate cancers. The main mechanism in cancer is a two-hit method where one allele is knocked out by one mutation (substitution, indel, breakpoint, or copy number deletion) and the other allele by a different mutation. In prostate cancer this work hints that this might not be the case for the majority of drivers.

This one was a lot of work but we got there in the end.
http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1007001

Comments

Popular posts from this blog

A census of amplified and overexpressed human cancer genes : Nature Reviews Cancer

RT @CancerInNorwich: 📢 Join us on Monday at 1pm for the next talk in our virtual seminar series. We will be hearing from Dr Wafa Al-Jamal from @QUBelfast, who will be talking about "Smart Nanomedicimes for Pancreatic Cancer". All are welcome to join via the MS Teams link: https://t.co/4xCYpjGuBZ https://t.co/EGyD4NAgeP

An excellent opportunity to join the cancer genetics team as a diagnostic lab bioinformatician in Norwich. Lots of exciting projects to get involved in. Deadline: 30/05/2023. Happy to chat about this role. https://t.co/SltGsxYF6Y https://t.co/zh08bqZFDb